DPP4 and type 2 diabetes mellitus: In contrast, a case–control study reported that DPP-4 inhibitors were associated with increased VTE risk in female T2DM patients only (OR 2.3,p = 0.0096).48However, details regarding confounding control were not clearly provided, as this was an additional analysis within the study.